Clinical Trials Logo

Clinical Trial Summary

Subjects receive study drug during bunionectomy and are followed for pain and opioid use, with the hypothesis that those who receive CPL-01 will have less pain and less opioid use than either control arm.


Clinical Trial Description

After signing informed consent, subjects will be randomly assigned to receive study drug (either Investigational product, positive control, or negative control) during unilateral distal bunionectomy with osteotomy. Subjects will then remain at the hospital for 72-hours where pain and rescue medication usage will be assessed. Follow-up will then occur at 7 and 30 days afterwards. The hypothesis is that subjects who receive CPL-01 will have less pain and require fewer opioids than subjects in the other two arms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05831449
Study type Interventional
Source Cali Pharmaceuticals LLC
Contact Erol Onel
Phone 2038376500
Email e.onel@calibiosciences.com
Status Recruiting
Phase Phase 3
Start date May 22, 2023
Completion date April 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT01435577 - Intravenous Tapentadol in Post-Bunionectomy Pain Phase 2
Terminated NCT05082012 - Early Weight-Bearing After the Lapiplasty Mini-Incision Procedure (Mini3D) N/A
Terminated NCT03257540 - Early Weight-Bearing After Lapidus Arthrodesis
Completed NCT04518462 - Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries Phase 3
Completed NCT04084262 - Multi-Plane Hallux Valgus Correction With the Phantom® Nail
Active, not recruiting NCT03740282 - Early Weight-Bearing After the Lapiplasty Procedure N/A
Completed NCT01743625 - Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain Phase 3
Completed NCT01484652 - Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension Phase 3
Terminated NCT01133639 - Ketorolac Effects on Post-operative Pain and Bone Healing N/A
Completed NCT04826328 - Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy Phase 1
Recruiting NCT05773846 - A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain Phase 3
Completed NCT03653429 - Efficacy of Tranexamic Acid in Foot and Ankle Surgeries Phase 4
Recruiting NCT04751344 - Liposomal Bupivacaine Versus Bupivacaine Plain for Operative Pain Management of Forefoot Surgery Phase 4
Withdrawn NCT03954639 - Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL Admixed With Bupi vs. Bupi Only Administered as Combined Sciatic and Adductor Canal Nerve Block for Postsurgical Analgesia in Lower Extremity Surgeries Phase 3
Completed NCT04002089 - Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy Phase 1
Terminated NCT02499575 - Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures N/A
Completed NCT00613938 - A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy. Phase 3
Completed NCT03246971 - Study of Wafermineâ„¢ for Post-bunionectomy or Abdominoplasty Pain Phase 2
Completed NCT00890682 - Study of Postoperative Analgesia in Bunionectomy Phase 3
Active, not recruiting NCT05602844 - Clinical Trial on Patient-Specific-Instrumentation Assisted Lapidus Fusion for Hallux Valgus N/A